ABHD4 | Abhydrolase domain containing 4 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
ABHD5 | Abhydrolase domain containing 5 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACR | Acrosin | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
APEH | Acylaminoacyl-peptide hydrolase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AZU1 | Azurocidin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
C1R | Complement component 1, r subcomponent | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C1RL | Complement component 1, r subcomponent-like | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C1S | Complement component 1, s subcomponent | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
C2 | Complement component 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CELA1 | Chymotrypsin-like elastase family, member 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CELA2A | Chymotrypsin-like elastase family, member 2A | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CELA2B | Chymotrypsin-like elastase family, member 2B | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CELA3A | Chymotrypsin-like elastase family, member 3A | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CELA3B | Chymotrypsin-like elastase family, member 3B | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFB | Complement factor B | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CFD | Complement factor D (adipsin) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CFI | Complement factor I | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CLPP | Caseinolytic mitochondrial matrix peptidase proteolytic subunit | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CMA1 | Chymase 1, mast cell | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
CORIN | Corin, serine peptidase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CPVL | Carboxypeptidase, vitellogenic-like | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CTRB1 | Chymotrypsinogen B1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CTRB2 | Chymotrypsinogen B2 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CTRC | Chymotrypsin C (caldecrin) | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
CTRL | Chymotrypsin-like | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
CTSA | Cathepsin A | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CTSG | Cathepsin G | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
DAG1 | Dystroglycan 1 (dystrophin-associated glycoprotein 1) | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DPP10 | Dipeptidyl-peptidase 10 (non-functional) | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DPP6 | Dipeptidyl-peptidase 6 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
DPP7 | Dipeptidyl-peptidase 7 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
DPP8 | Dipeptidyl-peptidase 8 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
DPP9 | Dipeptidyl-peptidase 9 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
ELANE | Elastase, neutrophil expressed | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
EPHX1 | Epoxide hydrolase 1, microsomal (xenobiotic) | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
F10 | Coagulation factor X | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
F11 | Coagulation factor XI | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
F12 | Coagulation factor XII (Hageman factor) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
F7 | Coagulation factor VII (serum prothrombin conversion accelerator) | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
F9 | Coagulation factor IX | Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FAP | Fibroblast activation protein, alpha | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FURIN | Furin (paired basic amino acid cleaving enzyme) | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
GZMA | Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Mixed |
GZMH | Granzyme H (cathepsin G-like 2, protein h-CCPX) | Enzymes Predicted secreted proteins
| | | | | Mixed |
GZMK | Granzyme K (granzyme 3; tryptase II) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
GZMM | Granzyme M (lymphocyte met-ase 1) | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HABP2 | Hyaluronan binding protein 2 | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |